Suppr超能文献

C 反应蛋白即时检测对养老院居民下呼吸道感染抗生素处方的影响:整群随机对照试验。

Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial.

机构信息

Department of Medicine for Older People, Amsterdam Public Health Research Institute, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands.

Department of Medicine for Older People, Amsterdam Public Health Research Institute, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands

出版信息

BMJ. 2021 Sep 21;374:n2198. doi: 10.1136/bmj.n2198.

Abstract

OBJECTIVE

To evaluate whether C reactive protein point-of-care testing (CRP POCT) safely reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents.

DESIGN

Pragmatic, cluster randomised controlled trial.

SETTING

The UPCARE study included 11 nursing home organisations in the Netherlands.

PARTICIPANTS

84 physicians from 11 nursing home organisations included 241 participants with suspected lower respiratory tract infections from September 2018 to the end of March 2020.

INTERVENTIONS

Nursing homes allocated to the intervention group had access to CRP POCT. The control group provided usual care without CRP POCT for patients with suspected lower respiratory tract infections.

MAIN OUTCOME MEASURES

The primary outcome measure was antibiotic prescribing at initial consultation. Secondary outcome measures were full recovery at three weeks, changes in antibiotic management and additional diagnostics during follow-up at one week and three weeks, and hospital admission and all cause mortality at any point (initial consultation, one week, or three weeks).

RESULTS

Antibiotics were prescribed at initial consultation for 84 (53.5%) patients in the intervention group and 65 (82.3%) in the control group. Patients in the intervention group had 4.93 higher odds (95% confidence interval 1.91 to 12.73) of not being prescribed antibiotics at initial consultation compared with the control group, irrespective of treating physician and baseline characteristics. The between group difference in antibiotic prescribing at any point from initial consultation to follow-up was 23.6%. Differences in secondary outcomes between the intervention and control groups were 4.4% in full recovery rates at three weeks (86.4% 90.8%), 2.2% in all cause mortality rates (3.5% 1.3%), and 0.7% in hospital admission rates (7.2% 6.5%). The odds of full recovery at three weeks, and the odds of mortality and hospital admission at any point did not significantly differ between groups.

CONCLUSIONS

CRP POCT for suspected lower respiratory tract infection safely reduced antibiotic prescribing compared with usual care in nursing home residents. The findings suggest that implementing CRP POCT in nursing homes might contribute to reduced antibiotic use in this setting and help to combat antibiotic resistance.

TRIAL REGISTRATION

Netherlands Trial Register NL5054.

摘要

目的

评估 C 反应蛋白即时检测(CRP POCT)是否能安全减少护理院居民下呼吸道感染的抗生素处方。

设计

实用、集群随机对照试验。

设置

UPCARE 研究包括荷兰的 11 个护理院组织。

参与者

11 个护理院组织的 84 名医生纳入了 241 名疑似下呼吸道感染的患者,这些患者来自 2018 年 9 月至 2020 年 3 月底。

干预措施

分配到干预组的护理院可以使用 CRP POCT。对照组为疑似下呼吸道感染的患者提供常规护理,不使用 CRP POCT。

主要观察指标

主要观察指标为初始咨询时的抗生素处方。次要观察指标为 3 周时完全康复,1 周和 3 周时抗生素管理和其他诊断的变化,以及任何时间(初始咨询、1 周或 3 周)的住院和全因死亡率。

结果

干预组 84 名(53.5%)患者和对照组 65 名(82.3%)患者在初始咨询时开具了抗生素。与对照组相比,干预组患者在初始咨询时不使用抗生素的可能性高出 4.93 倍(95%置信区间 1.91 至 12.73),无论治疗医生和基线特征如何。从初始咨询到随访的任何时间点,干预组与对照组之间的抗生素处方差异为 23.6%。干预组和对照组在 3 周时完全康复率(86.4% 90.8%)、全因死亡率(3.5% 1.3%)和住院率(7.2% 6.5%)方面的差异分别为 4.4%和 0.7%。3 周时完全康复的可能性以及任何时间点的死亡率和住院率在两组间无显著差异。

结论

与护理院常规护理相比,针对疑似下呼吸道感染的 CRP POCT 可安全减少抗生素处方。这些发现表明,在护理院中实施 CRP POCT 可能有助于减少该环境中的抗生素使用,并有助于对抗抗生素耐药性。

试验注册

荷兰试验注册 NL5054。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf2/8453309/4f61796492f7/boet065375.f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验